11/13/2025 | Press release | Distributed by Public on 11/13/2025 09:46
Vanderbilt (VU + VUMC): This is a combined competition for VU and VUMC investigators. All investigators should follow these instructions.
Vanderbilt (VU + VUMC, collaboratively) may nominate one candidate for the Mary Kay Foundation Innovative/Translational Cancer Research Grant program for 2026.
These awards provide $100,000 over two years to support innovative translational research for cancers predominantly affecting women, including but not limited to breast, cervical, endometrial, ovarian, and uterine cancers.
The Foundation seeks to fund innovative research that bridges laboratory discoveries and clinical application. Ultimately, such research would lead to improvement in the diagnosis, prognosis, prevention, or treatment of cancer.
You can find a list of the previous award recipients here. Review additional guidelines in the RFP.
Anyone interested in being considered as Vanderbilt's nominee must submit the following to [email protected] by 5 p.m. on Dec. 4. Please combine your materials into a single PDF and reference the program name in the subject line of the email.
The chosen nominee will submit a full proposal to the Foundation by the deadline of Feb. 1, 2026. Direct all questions about this opportunity to [email protected].